Is Tenax Therapeutics, Inc. (TENX) a Buy, Sell, or Hold?
NASDAQ : TENX
Tenax Therapeutics, Inc. — Institutional Ownership
$1.375 USD
-$12.06 (-89.77%)
- Volume
- 64.26M
- Average Volume
- 1.03M
- Market Capitalization
- $36.47M
- P/E Ratio
- -0.92
- Dividend Yield
- 0.00%
- Price Target
- $31.00
- Year High
- $19.40
- Year Low
- $1.31
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.07
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-31 | Christopher Thomas Giordano | 1.69M | 4.32% |
| 2026-07-30 | BlackRock, Inc. | 1.71M | 6.40% |
| 2026-07-08 | FMR LLC | 3.94M | 14.90% |
| 2026-06-05 | T. Rowe Price Associates, Inc. | 586.99K | 2.20% |
| 2026-05-20 | Millennium Management LLC | 1.35M | 5.10% |
| 2026-05-15 | Stonepine Capital Management, LLC | 975.2K | 3.70% |
| 2026-05-15 | BIOTECHNOLOGY VALUE FUND L P | 1.75M | 9.20% |
| 2026-05-15 | Dellora Investments Master Fund LP | 345.26K | 2.00% |
| 2026-05-15 | RTW Investments, LP | 1.87M | 9.90% |
| 2026-05-15 | Perceptive Advisors LLC | 1.45M | 5.50% |
| 2026-05-15 | Logos Global Management LP | 800K | 3.00% |
| 2026-05-15 | Lind Global Fund II LP | 202.48K | 0.78% |
| 2026-05-15 | Point72 Asset Management, L.P. | 533.96K | 3.10% |
| 2026-05-15 | Venrock Healthcare Capital Partners III, L.P. | 1.96M | 9.90% |
| 2026-05-08 | Integrated Core Strategies (US) LLC | 448.48K | 1.70% |
| 2026-05-07 | T. Rowe Price Associates, Inc. | 2.84M | 11.00% |
| 2026-05-07 | T. Rowe Price Associates, Inc. | 2.95M | 17.20% |
| 2026-05-04 | Invus Public Equities, L.P. | 366.14K | 2.10% |
| 2026-04-08 | Morgan Stanley | 596.56K | 3.50% |
| 2026-04-07 | Ikarian Capital, LLC | 1.15M | 6.70% |
| 2026-03-10 | Christopher Thomas Giordano | 1.25M | 6.79% |
| 2026-03-09 | Logos Global Management LP | 615K | 9.90% |
| 2026-02-17 | Point72 Asset Management, L.P. | 423.42K | 6.80% |
| 2026-02-17 | Perceptive Advisors LLC | 569.31K | 9.10% |
| 2026-02-17 | Venrock Healthcare Capital Partners III, L.P. | 692.96K | 9.90% |
| 2026-02-17 | Lind Global Fund II LP | 442.48K | 6.62% |
| 2026-02-17 | BIOTECHNOLOGY VALUE FUND L P | 596.43K | 7.80% |
| 2026-02-17 | RTW Investments, LP | 650.97K | 9.90% |
| 2026-02-17 | Dellora Investments Master Fund LP | 355.26K | 5.70% |
| 2026-02-12 | Morgan Stanley | 596.38K | 9.60% |
| 2025-12-23 | Perceptive Advisors LLC | 439.14K | 7.00% |
| 2025-12-08 | JANUS HENDERSON GROUP PLC | 623.73K | 9.99% |
| 2025-12-05 | Ikarian Capital, LLC | 967.6K | 15.50% |
| 2025-11-14 | Venrock Healthcare Capital Partners III, L.P. | 552.97K | 9.90% |
| 2025-11-14 | Lind Global Fund II LP | 442.48K | 8.80% |
| 2025-11-14 | Vestal Point Capital, LP | 2.47M | 9.90% |
| 2025-11-05 | Integrated Core Strategies (US) LLC | 313.71K | 6.90% |
| 2025-10-29 | Point72 Asset Management, L.P. | 339.63K | 7.40% |
| 2025-10-07 | Ikarian Capital, LLC | 967.6K | 21.20% |
| 2025-10-02 | Invus Public Equities, L.P. | 366.14K | 8.00% |
| 2025-08-14 | Venrock Healthcare Capital Partners III, L.P. | 449.49K | 9.90% |
| 2025-08-14 | JANUS HENDERSON GROUP PLC | 166.67K | 4.00% |
| 2025-06-30 | Integrated Core Strategies (US) LLC | 233.59K | 5.60% |
| 2025-05-15 | RTW Investments, LP | 418.44K | 9.99% |
| 2025-05-15 | Venrock Healthcare Capital Partners III, L.P. | 417.54K | 9.90% |
| 2025-05-14 | JANUS HENDERSON GROUP PLC | 396.64K | 9.90% |
| 2025-04-04 | Dellora Investments Master Fund LP | 305.26K | 7.70% |
| 2025-03-18 | S.H.N. Financial Investments Ltd. | 179.05K | 4.99% |
| 2025-02-14 | JANUS HENDERSON GROUP PLC | 193.18K | 5.40% |
| 2025-01-15 | Dellora Investments Master Fund LP | 305.26K | 9.00% |
| 2024-11-14 | Lind Global Fund II LP | 375K | 9.90% |
| 2024-11-14 | Lind Global Partners II LLC | 375K | 9.90% |
| 2024-11-14 | Jeff Easton | 375K | 9.90% |
| 2024-11-12 | Adage Capital Management, L.P. | 369.1K | 9.99% |
| 2024-11-12 | Robert Atchinson | 369.1K | 9.99% |
| 2024-11-12 | Phillip Gross | 369.1K | 9.99% |
| 2024-09-10 | 52-0556948 | 3.75M | 19.99% |
| 2024-08-19 | Biotechnology Value Fund II, L.P. | 140.06K | 4.10% |
| 2024-08-19 | BVF I GP LLC | 180.07K | 5.30% |
| 2024-08-19 | VHCP Management EG, LLC | 355.22K | 9.99% |
| 2024-08-19 | VHCP Management III, LLC | 355.22K | 9.99% |
| 2024-08-19 | Venrock Healthcare Capital Partners III, L.P. | 355.22K | 9.99% |
| 2024-08-19 | Biotechnology Value Fund, L.P. | 180.07K | 5.30% |
| 2024-08-19 | VHCP Co-Investment Holdings III, LLC | 355.22K | 9.99% |
| 2024-08-19 | Venrock Healthcare Capital Partners EG, L.P. | 355.22K | 9.99% |
| 2024-08-19 | Koh, Bong | 355.22K | 9.99% |
| 2024-08-19 | BVF Inc. | 340.66K | 9.99% |
| 2024-08-19 | BVF GP Holdings LLC | 320.13K | 9.40% |
| 2024-08-19 | BVF Partners OS Ltd. | 14696.0 | 1.00% |
| 2024-08-19 | Shah, Nimish | 355.22K | 9.99% |
| 2024-08-19 | Mark N. Lampert | 340.66K | 9.99% |
| 2024-08-19 | BVF Partners L.P. | 340.66K | 9.99% |
| 2024-08-19 | Biotechnology Value Trading Fund OS LP | 14696.0 | 1.00% |
| 2024-08-19 | BVF II GP LLC | 140.06K | 4.10% |
| 2024-08-15 | Stonepine GP, LLC | 372.8K | 11.00% |
| 2024-08-15 | Stonepine Capital Management, LLC | 372.8K | 11.00% |
| 2024-08-15 | Timothy P. Lynch | 372.8K | 11.00% |
| 2024-08-15 | Jon M. Plexico | 372.8K | 11.00% |
| 2024-08-15 | Stonepine Capital, L.P. | 372.8K | 11.00% |
| 2024-08-14 | Vivo Opportunity Fund Holdings, L.P. | 6.25M | 9.99% |
| 2024-08-14 | 00-0000000 | 359.85K | 9.90% |
| 2024-08-14 | EIN #00-0000000 | 359.85K | 9.90% |
| 2024-08-14 | Vivo Opportunity, LLC | 6.25M | 9.99% |
| 2024-02-20 | S.H.N. Financial Investments Ltd. | 107K | 5.60% |
| 2024-02-16 | CVI Investments, Inc. | 204.03K | 9.90% |
| 2024-02-16 | Heights Capital Management, Inc. | 204.03K | 9.90% |
| 2024-02-15 | Lind Global Fund II LP | 71500.0 | 9.90% |
| 2024-02-15 | Lind Global Partners II LLC | 71500.0 | 9.90% |
| 2024-02-15 | Jeff Easton | 71500.0 | 9.90% |
| 2022-09-23 | Andrea Rich 2021 Irrevocable Trust | 1.91M | 6.40% |
| 2022-09-23 | Stuart Rich | 4.31M | 14.30% |
| 2022-09-23 | Stuart Rich 2022 Irrevocable Trust | 1.91M | 6.40% |
| 2022-06-21 | Steven Boyd | 2.57M | 9.99% |
| 2022-06-21 | Armistice Capital, LLC | 2.57M | 9.99% |
| 2021-06-22 | Stuart Rich | 4.24M | 16.84% |
| 2021-06-22 | Doogan | 3.64M | 14.44% |
| 2020-03-23 | Steven Boyd | 421.14K | 5.60% |
| 2020-03-23 | Armistice Capital, LLC | 421.14K | 5.60% |
| 2020-03-23 | Armistice Capital Master Fund Ltd. | 421.14K | 5.60% |
| 2020-02-13 | 13-3127734 | 448.34K | 6.65% |
| 2020-02-13 | 26-0385758 | 448.34K | 6.65% |
| 2020-02-07 | (1) BlackRock, Inc. | 599.1K | 8.90% |
| 2019-02-12 | 26-0385758 | 164.74K | 5.46% |
| 2019-02-05 | Sander Gerber | 344.88K | 9.99% |
| 2019-02-05 | Hudson Bay Capital Management LP | 344.88K | 9.99% |
| 2018-12-14 | Kimberly Page | 569.95K | 9.99% |
| 2018-12-14 | Richard Abbe | 1.55M | 9.99% |
| 2018-12-14 | Iroquois Capital Management L.L.C. | 569.95K | 9.99% |
| 2018-02-14 | Peter Kolchinsky | - | 0.00% |
| 2018-02-14 | RA Capital Management, LLC | - | 0.00% |
| 2017-02-14 | RA Capital Management, LLC | 2.39M | 8.50% |
| 2017-02-14 | RA Capital Healthcare Fund, L.P. | - | 0.00% |
| 2017-02-14 | Peter Kolchinsky | 2.39M | 8.50% |
| 2014-09-26 | RA Capital Healthcare Fund, L.P. | 1.87M | 6.60% |
| 2014-09-26 | Peter Kolchinsky | 2.26M | 8.10% |
| 2014-09-26 | RA Capital Management, LLC | 2.26M | 8.10% |
| 2014-06-11 | Broadfin Capital, LLC | 1.52M | 5.45% |
| 2014-06-11 | Kevin Kotler | 1.52M | 5.45% |
| 2014-06-11 | Broadfin Healthcare Master Fund, Ltd. | 1.52M | 5.45% |
| 2014-03-28 | Dr. Jeffrey R. Jay, M.D. | 2M | 7.19% |
| 2014-03-28 | Mr. David Kroin | 2M | 7.19% |
| 2014-03-28 | Great Point Partners, LLC | 2M | 7.19% |
| 2014-03-18 | ANDREW M. WEISS, PH.D. | 3.28M | 6.00% |
| 2000-02-15 | 98-0186363 | 98.0 | 7.40% |
| 2000-02-15 | 98-0186363 | 98.0 | 7.40% |
TENX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $12.19 | 39.22M | $478.06M | $97.56M | -$ | $380.49M |
| 2024-12-31 | $6.19 | 15.27M | $94.53M | $94.85M | -$ | -$319.15K |
| 2023-12-31 | $21.97 | 248.45K | $5.46M | $9.79M | $500.9K | -$3.83M |
| 2022-12-31 | $177.60 | 18391 | $3.27M | $2.12M | $807.89K | $1.95M |
| 2021-12-31 | $1664.00 | 12860 | $21.4M | $5.58M | $290.78K | $16.11M |
| 2020-12-31 | $2976.00 | 4635 | $13.79M | $6.25M | $305.04K | $7.85M |
| 2019-12-31 | $2256.00 | 3872 | $8.74M | $4.91M | $171.73K | $4M |
| 2018-12-31 | $1936.00 | 915 | $1.77M | $12.37M | -$ | -$10.6M |
| 2017-12-31 | $15680.00 | 915 | $14.35M | $1.6M | -$ | $12.74M |
| 2016-12-31 | $62400.00 | 878 | $54.79M | $10M | -$ | $44.79M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14.55 | 50.87M | $740.15M | $117.98M | -$ | $622.17M |
| 2026-03-31 | $15.99 | 45.23M | $723.17M | $118.76M | -$ | $604.41M |
| 2025-12-31 | $12.19 | 39.22M | $478.06M | $97.56M | -$ | $380.49M |
| 2025-09-30 | $7.61 | 39.74M | $302.43M | $99.37M | -$ | $203.06M |
| 2025-06-30 | $5.76 | 39.57M | $227.94M | $105.46M | -$ | $122.47M |
| 2025-03-31 | $6.55 | 36.58M | $239.63M | $111.45M | -$ | $128.18M |
| 2024-12-31 | $6.19 | 15.27M | $94.53M | $94.85M | -$ | -$319.15K |
| 2024-09-30 | $3.46 | 21.16M | $73.22M | $98.31M | -$ | -$25.09M |
| 2024-06-30 | $3.00 | 1.96M | $5.87M | $9.38M | $278.8K | -$3.23M |
| 2024-03-31 | $3.82 | 1.22M | $4.66M | $12.55M | $413.17K | -$7.48M |
| 2023-12-31 | $21.97 | 298.28K | $6.55M | $9.79M | $500.9K | -$2.74M |
| 2023-09-30 | $23.92 | 298.28K | $7.13M | $11.14M | $174.47K | -$3.83M |